{"id":17766,"date":"2022-11-12T11:22:37","date_gmt":"2022-11-12T11:22:37","guid":{"rendered":"https:\/\/by-tv.co.uk\/?p=17766"},"modified":"2022-11-12T11:22:37","modified_gmt":"2022-11-12T11:22:37","slug":"ingiltere-tehlikeli-kis-virusu-rsvye-karsi-bebekleri-korumak-icin-gelistirilen-bir-asiya-onay-verdi","status":"publish","type":"post","link":"https:\/\/by-tv.co.uk\/en\/ingiltere-tehlikeli-kis-virusu-rsvye-karsi-bebekleri-korumak-icin-gelistirilen-bir-asiya-onay-verdi\/","title":{"rendered":"\u0130ngiltere tehlikeli k\u0131\u015f vir\u00fcs\u00fc RSV\u2019ye kar\u015f\u0131 bebekleri korumak i\u00e7in geli\u015ftirilen bir a\u015f\u0131ya onay verdi"},"content":{"rendered":"

Birle\u015fik Krall\u0131k\u2019ta \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenleme Kurumu MHRA, son yollarda giderek daha s\u0131k g\u00f6r\u00fclen tehlikeli k\u0131\u015f vir\u00fcs\u00fc RSV\u2019ye kar\u015f\u0131 bebekleri korumak i\u00e7in geli\u015ftirilen bir a\u015f\u0131ya onay verdi.<\/p>\n

Grip ve so\u011fuk alg\u0131nl\u0131\u011f\u0131na benzer belirtilerin g\u00f6r\u00fcld\u00fc\u011f\u00fc RSV (Respiratuar Sinsisyal Vir\u00fcs) hastal\u0131\u011f\u0131 t\u00fcm ya\u015f gruplar\u0131nda g\u00f6r\u00fcl\u00fcyor. Ancak bebekler ve ya\u015fl\u0131larda ya\u015fam\u0131 tehdit eden solunum yolu enfeksiyonlar\u0131na neden olabiliyor.
\nBBC\u2019nin haberine g\u00f6re MHRA\u2019n\u0131n onay verdi\u011fi, Sanofi ve AstraZeneca taraf\u0131ndan geli\u015ftirilen Nirsevimab adl\u0131 tek dozluk antikorun alt\u0131 aya kadar bebeklerin zat\u00fcrre ve bron\u015fit gibi g\u00f6\u011f\u00fcs hastal\u0131klar\u0131na yakalanmas\u0131n\u0131 b\u00fcy\u00fck oranda engelledi\u011fi belirtiliyor.<\/p>\n

4.000 bebekle yap\u0131lan denemelerde, a\u015f\u0131n\u0131n RSV kaynakl\u0131 solunum yolu hastal\u0131klar\u0131n\u0131 y\u00fczde 74,5 oran\u0131nda engelledi\u011fi g\u00f6r\u00fcld\u00fc.<\/p>

\"\"<\/a><\/div>\n

A\u015f\u0131n\u0131n, RSV\u2019nin solunum yollar\u0131nda h\u00fccrelere yap\u0131\u015farak enfeksiyonlara yol a\u00e7mas\u0131n\u0131 durdurdu\u011fu kaydediliyor.<\/p>\n

ABD\u2019de RSV i\u00e7in Pfizer taraf\u0131ndan geli\u015ftirilen bir a\u015f\u0131n\u0131n da klinik denemelerde iyi sonu\u00e7lar verdi\u011fi ifade ediliyor.<\/p>\n

Hamile kad\u0131nlara yap\u0131lan bu a\u015f\u0131n\u0131n bebeklerin ilk \u00fc\u00e7 ay\u0131nda RSV\u2019ye kar\u015f\u0131 y\u00fczde 81 oran\u0131nda koruma sa\u011flad\u0131\u011f\u0131 a\u00e7\u0131kland\u0131. Alt\u0131 ayl\u0131k koruma oran\u0131n\u0131n ise y\u00fczde 69 oldu\u011fu belirtildi.<\/p>\n

Pfizer, bu y\u0131l sonundan \u00f6nce a\u015f\u0131 i\u00e7in onay s\u00fcrecini ba\u015flatmay\u0131 planl\u0131yor.
\nRSV a\u015f\u0131s\u0131n\u0131n t\u00fcm bebeklere yap\u0131lmas\u0131 i\u00e7in ara\u015ft\u0131rmalar s\u00fcr\u00fcyor.<\/p>\n

\"\"<\/a><\/div>","protected":false},"excerpt":{"rendered":"

Birle\u015fik Krall\u0131k\u2019ta \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenleme Kurumu MHRA, son yollarda giderek daha s\u0131k g\u00f6r\u00fclen tehlikeli k\u0131\u015f vir\u00fcs\u00fc RSV\u2019ye kar\u015f\u0131 bebekleri korumak i\u00e7in geli\u015ftirilen bir a\u015f\u0131ya onay verdi. Grip ve so\u011fuk alg\u0131nl\u0131\u011f\u0131na benzer belirtilerin g\u00f6r\u00fcld\u00fc\u011f\u00fc RSV (Respiratuar Sinsisyal Vir\u00fcs) hastal\u0131\u011f\u0131 t\u00fcm ya\u015f gruplar\u0131nda g\u00f6r\u00fcl\u00fcyor. Ancak bebekler ve ya\u015fl\u0131larda ya\u015fam\u0131 tehdit eden solunum yolu enfeksiyonlar\u0131na neden olabiliyor. BBC\u2019nin haberine g\u00f6re MHRA\u2019n\u0131n onay verdi\u011fi, Sanofi ve AstraZeneca taraf\u0131ndan geli\u015ftirilen Nirsevimab adl\u0131 tek dozluk antikorun alt\u0131 aya kadar bebeklerin zat\u00fcrre ve bron\u015fit gibi g\u00f6\u011f\u00fcs hastal\u0131klar\u0131na yakalanmas\u0131n\u0131 b\u00fcy\u00fck oranda engelledi\u011fi belirtiliyor. 4.000 bebekle yap\u0131lan denemelerde, a\u015f\u0131n\u0131n RSV kaynakl\u0131 solunum yolu hastal\u0131klar\u0131n\u0131 y\u00fczde 74,5 oran\u0131nda […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-17766","post","type-post","status-publish","format-standard","hentry","category-genel"],"_links":{"self":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/17766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/comments?post=17766"}],"version-history":[{"count":0,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/posts\/17766\/revisions"}],"wp:attachment":[{"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/media?parent=17766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/categories?post=17766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/by-tv.co.uk\/en\/wp-json\/wp\/v2\/tags?post=17766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}